| Mrs Linda Marie Anton, MS | |
|
17280 W North Ave, #104, Brookfield, WI 53045-4366 | |
| (262) 780-0707 | |
| (262) 780-0717 |
| Full Name | Mrs Linda Marie Anton |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 17280 W North Ave, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124091350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 986154 (Wisconsin) | Primary |
| Provider Name | Prohealth Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.
Researchers have examined the evidence in favour of giving people considered to be close to developing dementia the drugs that are most commonly used to treat the condition itself.
Failure to comply with international exposure recommendations for air pollution, noise, heat and access to green space is associated with more than 1,000 deaths per year in Barcelona and more than 900 in Madrid, accounting for 7% and 3% of overall premature mortality, respectively.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Linda Marie Anton, MS 17280 W North Ave, #104, Brookfield, WI 53045-4366 Ph: (262) 780-0707 | Mrs Linda Marie Anton, MS 17280 W North Ave, #104, Brookfield, WI 53045-4366 Ph: (262) 780-0707 |
News Archive
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that it has dosed the first patient in a Phase 2 trial evaluating AKB-9778, a Tie2 activator, alone and in combination with ranibizumab (Lucentis) for the treatment of diabetic macular edema (DME). AKB-9778 is a first-in-class inhibitor of human protein tyrosine phosphatase beta (HPTPβ) that activates the Tie2 pathway to promote vascular stability, preventing abnormal blood vessel growth and vascular leak.
In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.
Researchers have examined the evidence in favour of giving people considered to be close to developing dementia the drugs that are most commonly used to treat the condition itself.
Failure to comply with international exposure recommendations for air pollution, noise, heat and access to green space is associated with more than 1,000 deaths per year in Barcelona and more than 900 in Madrid, accounting for 7% and 3% of overall premature mortality, respectively.
› Verified 1 days ago
Katie Elizabeth Gubbins, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3360 Gateway Rd, Brookfield, WI 53045 Phone: 414-339-5542 | |
Kate Jablonski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 | |
Mrs. Erica Lee Lyons, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17700 W Capitol Dr, Brookfield, WI 53045 Phone: 262-781-3083 Fax: 262-781-3080 | |
Mrs. Sandra K Merkel, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1305 N Barker Rd, Brookfield, WI 53045 Phone: 262-391-5314 | |
Madeleine Elizabeth Fitzgerald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Patrick Blvd Ste 250, Brookfield, WI 53045 Phone: 888-754-0398 | |
Amy Unger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 | |
Lindy Marie Frechette, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3360 Gateway Rd Ste 100, Brookfield, WI 53045 Phone: 262-295-6289 |